IncFact
Company Profiles: Revenue, Growth, Competition

AMICUS THERAPEUTICS US Revenue, Growth & Competitor Profile

DBA AMICUS THERAPEUTICS, INC.
Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Amicus Therapeutics US

Access the complete profile.

Amicus Therapeutics US Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
Address1 Cedar Brook Dr
Cranbury, NJ 08512

amicusrx.com


Amicus Therapeutics US's annual revenues are $100-$500 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Scientific Research & Development Services industry.


Amicus Therapeutics US's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Amicus Therapeutics US is a publicly traded company on NGM using the ticker symbol FOLD. Detailed information on company financials and operating reports can be found here: NGM: FOLD



Amicus Therapeutics US Annual Revenue and Growth Rate

Amicus Therapeutics US Revenue Est.
($ Million)
Growth Rate (%)# Employees
2019 Details in Premium Report
2018
2017
2016
2015
2014


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Amicus Therapeutics US's revenues are gauged from an analysis of company filings.



Investor Activity

Amicus Therapeutics US has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
July 19, 2016 18 100%$5 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Amicus Therapeutics US is developing and marketing. Amicus Therapeutics US's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
POMBILITI
Pharmaceutical preparations for the treatment of Pompe disease; Pharmaceutical preparations for the treatment of genetic diseases
05/22/2020
UPOMVI
Pharmaceutical preparations for the treatment of Pompe disease; Pharmaceutical preparations for the treatment of genetic diseases
05/22/2020
RENJOZY
Pharmaceutical preparations for the treatment of Pompe disease; Pharmaceutical preparations for the treatment of genetic diseases
05/22/2020

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Amicus Therapeutics US grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Amicus Therapeutics US is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Scientific Research & Development Services

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Amicus Therapeutics US's Largest Competitors

A competitive analysis shows these companies are in the same general field as Amicus Therapeutics US, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
OMNICARECincinnati, OH100 
LEIDOSReston, VA91 
INC RESEARCHMorrisville, NC62 
SCIENCE APPLICATIONS INTERNATIONALReston, VA61 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM49 
CEPHALONFrazer, PA44 
COVANCEPrinceton, NJ35 
SYNEOS HEALTHRaleigh, NC29 
INCYTEWilmington, DE29 




Nearby Competitors

These companies are similar in business line and location to Amicus Therapeutics US. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
COVANCEPrinceton, NJ100 
AMICUS THERAPEUTICS USCranbury, NJ4 
ADVAXISPrinceton, NJ3 
TAIHO ONCOLOGYPrinceton, NJ2 
HOVIONEEast Windsor, NJ1 
PRINCTON SCIENCE INC. SCITECPrinceton, NJ1 




Future Competition: Amicus Therapeutics US's Fastest Growing Competitors

These companies are in the same general field as Amicus Therapeutics US and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Amicus Therapeutics US Competitors